Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
Campus

Managing the Recurrent ASCVD Risks of Your ACS Patient: A call to Action – GULF Perspective: Part 3

Dyslipidemia management in post-ACS patients has proven to be challenging in various aspects, thus, the observed gaps between clinical practice and guidelines' recommendations accentuate the need for a call-to-action to achieve a comprehensive approach in the management of LDL cholesterol.

Watch the third and last episode of the interview conducted with Professor Mohamed Balgaith, an interventional cardiologist at King Abdulaziz Cardiac Center National Guard Riyadh, discussing the current level of dyslipidemia management in post-ACS patients while introducing possible strategies to facilitate achieving the guidelines recommended for LDL-C targets.

Back to main page

Related articles
Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Prospective evaluation of lipid management following ACS in Saudi Arabia (ACOSYM Study)

Watch the video tackling the critical topic of dyslipidemia management post-acute coronary syndrome. Globally, despite its pivotal role in secondary prevention, the approach remains suboptimal, so we'll dissect Arafah MR et al recent publication, providing a detailed evaluation of lipid management after ACS in Saudi Arabia. Specifically, shining a spotlight on LDL-cholesterol management and delve into the complications of statin use in post-ACS Saudi patients.

Read article
Statin/ezetimibe SPC for better adherence to LLT

Statin/ezetimibe SPC for better adherence to LLT

This large cohort study of patients from the Lombardy region (Italy) demonstrated that the single-pill combination of statin and ezetimibe substantially improved adherence to drug therapy vs the two-pill combination of respective drugs.

Read article
Lp(a) and PCSK9 inhibition in nominally controlled LDL-C patients

Lp(a) and PCSK9 inhibition in nominally controlled LDL-C patients

Read article
MAT-KW-2400382/v1/Aug 2024